Breaking News Instant updates and real-time market news.

PTCT

PTC Therapeutics

$39.72 /

+0.33 (+0.84%)

, SRPT

Sarepta

$86.81 /

-0.53 (-0.61%)

06:52
03/23/20
03/23
06:52
03/23/20
06:52

Sarepta, DBV among Citi's SMid Biotech picks amid coronavirus outbreak

Analyst Joel Beatty laid out Citi's picks in SMid Biotech that are expected to be less negatively impacted from the coronavirus outbreak, and therefore should outperform relative to peers. The stocks picks are: PTC Therapeutics (PTCT), Sarepta (SRPT), Ionis Pharmaceuticals (IONS), Halozyme (HALO), Mirum Pharmaceuticals (MIRM), DBV Technologies (DBVT), Syndax (SNDX), Minerva (NERV), X4 Pharmaceuticals (XFOR), Millendo Therapeutics (MLND) and CymaBay (CBAY).

PTCT

PTC Therapeutics

$39.72 /

+0.33 (+0.84%)

SRPT

Sarepta

$86.81 /

-0.53 (-0.61%)

IONS

Ionis Pharmaceuticals

$43.59 /

-2.41 (-5.24%)

HALO

Halozyme

$15.57 /

+0.59 (+3.94%)

MIRM

Mirum Pharmaceuticals

$11.43 /

+0.51 (+4.67%)

DBVT

DBV Technologies

$3.63 /

+0.37 (+11.35%)

SNDX

Syndax

$8.55 /

+0.035 (+0.41%)

NERV

Minerva

$4.95 /

+0.11 (+2.27%)

XFOR

X4 Pharmaceuticals

$8.44 /

-0.13 (-1.52%)

MLND

Millendo Therapeutics

$6.01 /

+ (+0.00%)

CBAY

CymaBay

$1.39 /

+0.09 (+6.92%)

  • 24

    Mar

  • 15

    May

  • 24

    May

  • 05

    Aug

PTCT PTC Therapeutics
$39.72 /

+0.33 (+0.84%)

03/03/20 Cantor Fitzgerald
PTC Therapeutics price target raised to $86 from $81 at Cantor Fitzgerald
02/20/20 RBC Capital
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
02/20/20 Citi
PTC Therapeutics downgraded to Neutral from Buy at Citi
02/20/20 RBC Capital
PTC Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
SRPT Sarepta
$86.81 /

-0.53 (-0.61%)

02/27/20 Cantor Fitzgerald
Sarepta price target raised to $217 from $211 at Cantor Fitzgerald
02/27/20 JMP Securities
Sarepta price target lowered to $217 from $280 at JMP Securities
01/23/20 SVB Leerink
SVB Leerink sees 'limited' repercussions from release of Vyondys53 CRL
01/22/20 RBC Capital
Sarepta CRL release confirms management messaging, says RBC Capital
IONS Ionis Pharmaceuticals
$43.59 /

-2.41 (-5.24%)

03/05/20 Cantor Fitzgerald
Ionis study suspension has limited read to ongoing Phase 3, says Cantor
03/05/20 Wells Fargo
Ionis should be bought on misreading of trial suspension, says Wells Fargo
03/05/20
Fly Intel: Top five analyst initiations
03/05/20 Citi
Ionis Pharmaceuticals initiated with a Buy at Citi
HALO Halozyme
$15.57 /

+0.59 (+3.94%)

02/05/20
Fly Intel: Top five analyst upgrades
02/05/20 Piper Sandler
Halozyme upgraded to Overweight from Neutral at Piper Sandler
01/27/20 Cantor Fitzgerald
Halozyme price target raised to $35 from $27 at Cantor Fitzgerald
01/09/20 BMO Capital
Halozyme upgraded to Outperform from Market Perform at BMO Capital
MIRM Mirum Pharmaceuticals
$11.43 /

+0.51 (+4.67%)

12/17/19 Citi
Mirum Pharmaceuticals price target raised to $30 from $21 at Citi
12/16/19 Roth Capital
Mirum update shortens development timeframe by two years, says Roth Capital
08/12/19
Fly Intel: Top five analyst initiations
08/12/19 Raymond James
Mirum Pharmaceuticals initiated with an Outperform at Raymond James
DBVT DBV Technologies
$3.63 /

+0.37 (+11.35%)

03/20/20 Kepler Cheuvreux
DBV Technologies downgraded to Hold from Buy at Kepler Cheuvreux
03/18/20 Bryan Garnier
DBV Technologies downgraded to Neutral from Buy at Bryan Garnier
03/17/20 Baird
Aimmune price target lowered to $58 from $64 at Baird
03/17/20 H.C. Wainwright
DBV can address FDA concerns on patch adhesion, says H.C. Wainwright
SNDX Syndax
$8.55 /

+0.035 (+0.41%)

03/12/20 Citi
Syndax price target raised to $18 from $12 at Citi
03/05/20 Nomura Instinet
Syndax upcoming Phase 3 readout will be 'clearing event, says Nomura Instinet
03/04/20 Baird
Syndax price target raised to $27 from $20 at Baird
03/04/20 Barclays
Syndax initiated with an Overweight at Barclays
NERV Minerva
$4.95 /

+0.11 (+2.27%)

12/19/19 JMP Securities
JMP maintains Outperform on Minerva, lowers target to $18 after MIN-117 failure
12/19/19 Citi
Minerva selloff on trial miss a buying opportunity, says Citi
10/02/19 H.C. Wainwright
Minerva investors 'missing the forest for the trees,' says H.C. Wainwright
09/25/19 Chardan
Minerva initiated with a Buy at Chardan
XFOR X4 Pharmaceuticals
$8.44 /

-0.13 (-1.52%)

02/13/20 Roth Capital
X4 patent strengthens commercial outlook for mavorixafor, says Roth
01/07/20 H.C. Wainwright
X4 Pharmaceuticals initiated with a Buy at H.C. Wainwright
12/30/19 Roth Capital
X4 Pharmaceuticals study initiation a positive sign, says Roth Capital
12/23/19 Oppenheimer
X4 Pharmaceuticals initiated with an Outperform at Oppenheimer
MLND Millendo Therapeutics
$6.01 /

+ (+0.00%)

01/10/20 Roth Capital
Millendo Therapeutics initiated with a Buy at Roth Capital
09/16/19 Jefferies
Millendo Therapeutics assumed with a Buy at Jefferies
07/19/19 Wedbush
Millendo Therapeutics initiated with an Outperform at Wedbush
07/18/19 Wedbush
Millendo Therapeutics initiated with an Outperform at Wedbush
CBAY CymaBay
$1.39 /

+0.09 (+6.92%)

03/13/20 Oppenheimer
CymaBay upgraded to Outperform from Perform at Oppenheimer
03/13/20 Cantor Fitzgerald
CymaBay upgraded to Overweight from Neutral at Cantor Fitzgerald
02/26/20 Citi
Citi upgrades Intercept to Buy on peak sales potential of Ocaliva
01/02/20 Citi
Intercept downgraded to Neutral from Buy at Citi

TODAY'S FREE FLY STORIES

Hot Stocks
Woodward withdraws FY20 guidance » 07:55
04/06/20
04/06
07:55
04/06/20
07:55
WWD

Woodward

$51.33 /

-1.69 (-3.19%)

Due to the significant…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Woodward announces workforce management, salary reductions, wage freeze » 07:55
04/06/20
04/06
07:55
04/06/20
07:55
WWD

Woodward

$51.33 /

-1.69 (-3.19%)

Woodward is implementing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Immunomedics to host conference call » 07:55
04/06/20
04/06
07:55
04/06/20
07:55
IMMU

Immunomedics

$9.39 /

-1.25 (-11.75%)

Management to provide a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Incyte to host conference call » 07:55
04/06/20
04/06
07:55
04/06/20
07:55
INCY

Incyte

$78.68 /

+1.67 (+2.17%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Woodward CEO says management of cash flow will be key focus » 07:53
04/06/20
04/06
07:53
04/06/20
07:53
WWD

Woodward

$51.33 /

-1.69 (-3.19%)

Woodward announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Wintrust Financial upgraded to Strong Buy from Outperform at Raymond James » 07:53
04/06/20
04/06
07:53
04/06/20
07:53
WTFC

Wintrust Financial

$31.14 /

-0.63 (-1.98%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Immunomedics appoints Harout Semerjian as president, CEO » 07:52
04/06/20
04/06
07:52
04/06/20
07:52
IMMU

Immunomedics

$9.39 /

-1.25 (-11.75%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

Immunomedics (IMMU)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Webster Financial double upgraded to Strong Buy at Raymond James » 07:52
04/06/20
04/06
07:52
04/06/20
07:52
WBS

Webster Financial

$21.23 /

+0.2 (+0.95%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Raymond James cuts estimates and targets for residential mortgage REITs » 07:51
04/06/20
04/06
07:51
04/06/20
07:51
AJX

Great Ajax

$4.47 /

+0.06 (+1.36%)

, NRZ

New Residential

$3.33 /

-0.93 (-21.83%)

, RWT

Redwood Trust

$2.57 /

-0.435 (-14.50%)

, TWO

Two Harbors

$2.42 /

-0.985 (-28.97%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
United Bankshares upgraded to Outperform from Market Perform at Raymond James » 07:50
04/06/20
04/06
07:50
04/06/20
07:50
UBSI

United Bankshares

$21.97 /

-0.88 (-3.85%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
First Mid-Illinois Bancshares upgraded to Strong Buy from Outperform at Raymond James » 07:49
04/06/20
04/06
07:49
04/06/20
07:49
FMBH

First Mid-Illinois Bancshares

$21.64 /

+0.11 (+0.51%)

Raymond James upgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Albemarle price target lowered to $80 from $115 at BMO Capital » 07:49
04/06/20
04/06
07:49
04/06/20
07:49
ALB

Albemarle

$52.72 /

-0.92 (-1.72%)

BMO Capital analyst Joel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Commerce Bancshares upgraded to Market Perform from Underperform at Raymond James » 07:48
04/06/20
04/06
07:48
04/06/20
07:48
CBSH

Commerce Bancshares

$48.58 /

-3 (-5.82%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
FTI Consulting upgraded to Outperform from Market Perform at William Blair » 07:47
04/06/20
04/06
07:47
04/06/20
07:47
FCN

FTI Consulting

$121.88 /

+1.39 (+1.15%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Jacobs awarded $29M cybersecurity support contract by USPTO » 07:46
04/06/20
04/06
07:46
04/06/20
07:46
J

Jacobs

$78.99 /

-2.26 (-2.78%)

Jacobs was selected by…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Hexcel says liquidity position 'solid' » 07:46
04/06/20
04/06
07:46
04/06/20
07:46
HXL

Hexcel

$31.57 /

-1.17 (-3.57%)

Hexcel said it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
NXP Semiconductors price target lowered to $115 from $145 at Raymond James » 07:45
04/06/20
04/06
07:45
04/06/20
07:45
NXPI

NXP Semiconductors

$75.76 /

-2.05 (-2.63%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Hexcel adopts limited duration shareholder rights plan after ending merger pact » 07:45
04/06/20
04/06
07:45
04/06/20
07:45
HXL

Hexcel

$31.57 /

-1.17 (-3.57%)

, WWD

Woodward

$51.33 /

-1.69 (-3.19%)

Hexcel Corporation (HXL)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Albany International closes some facilities in response to COVID-19 pandemic » 07:44
04/06/20
04/06
07:44
04/06/20
07:44
AIN

Albany International

$41.89 /

-1.98 (-4.51%)

Albany International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Immunomedics trading halted, news pending  07:44
04/06/20
04/06
07:44
04/06/20
07:44
IMMU

Immunomedics

$9.39 /

-1.25 (-11.75%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Microchip price target lowered to $100 from $125 at Raymond James » 07:44
04/06/20
04/06
07:44
04/06/20
07:44
MCHP

Microchip

$64.04 /

-1.1 (-1.69%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Innovation Pharmaceuticals in talks to advance brilacidin into human trials » 07:43
04/06/20
04/06
07:43
04/06/20
07:43
IPIX

Innovation Pharmaceuticals

$0.00 /

+ (+0.00%)

Innovation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Analog Devices price target lowered to $100 from $140 at Raymond James » 07:43
04/06/20
04/06
07:43
04/06/20
07:43
ADI

Analog Devices

$86.56 /

-1.21 (-1.38%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Intel in the right place at the right time during pandemic, says Raymond James » 07:41
04/06/20
04/06
07:41
04/06/20
07:41
INTC

Intel

$54.20 /

-0.18 (-0.33%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Emerald Health releases first harvest of cannabis from Richmond, BC facility » 07:41
04/06/20
04/06
07:41
04/06/20
07:41
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

Emerald Health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.